Reduced hypothalamic vasopressin secretion underlies attenuated adrenocorticotropin stress responses in pregnant rats.
暂无分享,去创建一个
[1] M. S. King,et al. The role of intracellular messengers in adrenocorticotropin secretion in vitro , 1990, Experientia.
[2] S. Matthews,et al. Programming of the Hypothalamo–Pituitary–Adrenal Axis: Serotonergic Involvement , 2004, Stress.
[3] G. Tsujimoto,et al. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. , 2004, The Journal of clinical investigation.
[4] A. Douglas,et al. Neuroendocrine responses to stress in mice: hyporesponsiveness in pregnancy and parturition. , 2003, Endocrinology.
[5] Simona Volpi,et al. Translational regulation of the vasopressin v1b receptor involves an internal ribosome entry site. , 2003, Molecular endocrinology.
[6] J. Russell,et al. Hypothalamic‐Pituitary‐Adrenal Responses to Centrally Administered Orexin‐A are Suppressed in Pregnant Rats , 2003, Journal of neuroendocrinology.
[7] N. Toschi,et al. No stress response of the hypothalamo-pituitary-adrenal axis in parturient rats: lack of involvement of brain oxytocin. , 2003, Endocrinology.
[8] D. Grigoriadis,et al. Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. , 2003, Endocrinology.
[9] S. Volpi,et al. Transcriptional and post-transcriptional mechanisms regulating the rat pituitary vasopressin V1b receptor gene. , 2003, Journal of molecular endocrinology.
[10] M. Roche,et al. Circuitry Underlying Regulation of the Serotonergic System by Swim Stress , 2003, The Journal of Neuroscience.
[11] M. Shipston,et al. Posttranslational modulation of glucocorticoid feedback inhibition at the pituitary level. , 2002, Endocrinology.
[12] C. Wotjak,et al. Vasopressin from hypothalamic magnocellular neurons has opposite actions at the adenohypophysis and in the supraoptic nucleus on ACTH secretion , 2002, The European journal of neuroscience.
[13] M. Weinstock. Can the Behaviour Abnormalities Induced by Gestational Stress in Rats be Prevented or Reversed? , 2002, Stress.
[14] F. Holsboer,et al. Vasopressin Mediates the Response of the Combined Dexamethasone/CRH Test in Hyper-anxious Rats: Implications for Pathogenesis of Affective Disorders , 2002, Neuropsychopharmacology.
[15] S. Lightman,et al. Hypothalamic and amygdaloid corticotropin-releasing hormone (CRH) and CRH receptor-1 mRNA expression in the stress-hyporesponsive late pregnant and early lactating rat. , 2001, Brain research. Molecular brain research.
[16] G. Aguilera,et al. Regulation of pituitary corticotropin releasing hormone receptors , 2001, Peptides.
[17] J. Seckl,et al. Prenatal Stress, Glucocorticoids and the Programming of the Brain , 2001, Journal of neuroendocrinology.
[18] A. Burlet,et al. Increased Colocalization of Corticotropin‐Releasing Factor and Arginine Vasopressin in Paraventricular Neurones of the Hypothalamus in Lactating Rats: Evidence from Immunotargeted Lesions and Immunohistochemistry , 2001, Journal of neuroendocrinology.
[19] S. Maccari,et al. Hormonal and Behavioural Abnormalities Induced by Stress in utero: an Animal Model for Depression , 2001, Stress.
[20] A. Burlet,et al. Increased colocalization of corticotropin-releasing factor and arginine vasopressin in paraventricular neurones of the hypothalamus in lactating rats: evidence from immunotargeted lesions and immunohistochemistry. , 2001 .
[21] S. Lightman,et al. Peripartum plasticity within the hypothalamo-pituitary-adrenal axis. , 2001, Progress in brain research.
[22] J. Seckl,et al. Attenuation of Hypothalamic‐Pituitary‐Adrenal Axis Stress Responses in Late Pregnancy: Changes in Feedforward and Feedback Mechanisms , 2000, Journal of neuroendocrinology.
[23] G. Chrousos,et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[24] F. Antoni. Molecular Diversity of Cyclic AMP Signalling , 2000, Frontiers in Neuroendocrinology.
[25] Preziosi,et al. Evidence That Hydrogen Sulphide Can Modulate Hypothalamo‐Pituitary‐Adrenal Axis Function: In Vitro and In Vivo Studies in the Rat , 2000, Journal of neuroendocrinology.
[26] G. Aguilera,et al. Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat , 2000, Experimental physiology.
[27] F. Holsboer,et al. Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats. , 2000, The Journal of endocrinology.
[28] L. Muglia,et al. Pituitary-Adrenal Axis Regulation in Crh-Deficient Mice , 2000, Endocrine research.
[29] D. Jezova,et al. Central corticotropin-releasing hormone receptors modulate hypothalamic–pituitary–adrenocortical and sympathoadrenal activity during stress , 1999, Neuroscience.
[30] D. Toufexis,et al. Altered Pituitary Sensitivity to Corticotropin‐Releasing Factor and Arginine Vasopressin Participates in the Stress Hyporesponsiveness of Lactation in the Rat , 1999, Journal of neuroendocrinology.
[31] M. Wong,et al. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. , 1999, Life sciences.
[32] Paulus S. Wang,et al. Effects of estradiol on corticosterone secretion in ovariectomized rats , 1999, Journal of cellular biochemistry.
[33] S. Maier,et al. The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress * , 1998 .
[34] R. Landgraf,et al. The role of endogenous opioids in neurohypophysial and hypothalamo-pituitary-adrenal axis hormone secretory responses to stress in pregnant rats. , 1998, The Journal of endocrinology.
[35] S. Lightman,et al. The arginine vasopressin and corticotrophin‐releasing hormone gene transcription responses to varied frequencies of repeated stress in rats , 1998, The Journal of physiology.
[36] G. Aguilera,et al. Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C. , 1998, Endocrinology.
[37] G. Aguilera,et al. Interaction Between Glucocorticoids and Corticotropin Releasing Hormone (CRH) in the Regulation of the Pituitary CRH Receptor in vivo , 1998, Journal of neuroendocrinology.
[38] M. Shipston,et al. Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes , 1998, The Journal of physiology.
[39] G. Chrousos,et al. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. , 1998, Endocrinology.
[40] G. Aguilera,et al. Regulation of pituitary V1b vasopressin receptor messenger ribonucleic acid by adrenalectomy and glucocorticoid administration. , 1997, Endocrinology.
[41] G. Aguilera,et al. Regulation of Pituitary Corticotropin Releasing Hormone (CRH) Receptor mRNA and CRH Binding During Adrenalectomy: Role of Glucocorticoids and Hypothalamic Factors , 1997, Journal of neuroendocrinology.
[42] Y. Oiso,et al. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I: Effects of the common secretagogues. , 1997, Endocrinology.
[43] S. Lightman,et al. Rapid changes in heteronuclear RNA for corticotrophin-releasing hormone and arginine vasopressin in response to acute stress. , 1997, The Journal of endocrinology.
[44] G. Chrousos,et al. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. , 1996, Endocrinology.
[45] S. Rivest,et al. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF. , 1996, Endocrinology.
[46] R. Binnekade,et al. Short Stressor Induced Long‐Lasting Increases of Vasopressin Stores in Hypothalamic Corticotropin‐Releasing Hormone (CRH) Neurons in Adult Rats , 1996, Journal of neuroendocrinology.
[47] Y. Kuryshev,et al. Corticotropin-releasing hormone stimulates Ca2+ entry through L- and P-type Ca2+ channels in rat corticotropes. , 1996, Endocrinology.
[48] L. Bilezikjian,et al. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. , 1996, Endocrinology.
[49] G. Aguilera,et al. Regulation of Pituitary Vasopressin V1b Receptor mRNA during Stress in the Rat , 1995, Journal of neuroendocrinology.
[50] P. J. Larsen,et al. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant‐induced arthritis , 1995, British journal of pharmacology.
[51] E. Schmidt,et al. Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[52] G. Aguilera,et al. Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids. , 1995, Endocrinology.
[53] C. Walker,et al. Dissociation Between Behavioral and Hormonal Responses to the Forced Swim Stress in Lactating Rats , 1995, Journal of neuroendocrinology.
[54] L. Mahan,et al. Extrapituitary expression of the rat V1b vasopressin receptor gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[55] X. Wang,et al. Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress. , 1995, Neuroendocrinology.
[56] B. Waddell,et al. The hypothalamic-pituitary-adrenal axis in rat pregnancy and lactation: circadian variation and interrelationship of plasma adrenocorticotropin and corticosterone. , 1995, Endocrinology.
[57] G. Aguilera,et al. Stress‐Specific Regulation of Corticotropin Releasing Hormone Receptor Expression in the Paraventricular and Supraoptic Nuclei of the Hypothalamus in the Rat , 1994, Journal of neuroendocrinology.
[58] C. Donaldson,et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[59] G. Aguilera,et al. Regulation of Pituitary Vasopressin Receptors during Chronic Stress: Relationship to Corticotroph Responsiveness , 1994, Journal of neuroendocrinology.
[60] Y. Arsenijévic,et al. Vasopressin-binding sites in the pig pituitary gland: competition by novel vasopressin antagonists suggests the existence of an unusual receptor subtype in the anterior lobe. , 1994, Journal of Endocrinology.
[61] Changes in Pro‐Opiomelanocortin and Pre‐proenkephalin mRNA Levels in the Ovine Brain during Pregnancy, Parturition and Lactation and in Response to Oestrogen and Progesterone , 1993, Journal of neuroendocrinology.
[62] R. Hauger,et al. Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin. , 1993, Endocrinology.
[63] F. Antoni. Vasopressinergic Control of Pituitary Adrenocorticotropin Secretion Comes of Age , 1993, Frontiers in Neuroendocrinology.
[64] D. Jezova,et al. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. , 1993, Endocrinology.
[65] S. Stoev,et al. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin. , 1992, Journal of medicinal chemistry.
[66] D. Jezova,et al. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. , 1991, Neuroendocrinology.
[67] James L. Roberts,et al. Positive regulation of proopiomelanocortin gene expression in corticotropes and melanotropes , 1991 .
[68] R. Vranckx,et al. Effect of adrenalectomy at different pregnancy stages on maternal and fetal serum corticosteroid binding globulin and corticosterone in the rat. , 1990, Acta endocrinologica.
[69] G. Aguilera,et al. Protein kinase C mediates the effect of vasopressin in pituitary corticotrophs. , 1989, Molecular endocrinology.
[70] G. Dayanithi,et al. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein. , 1989, Endocrinology.
[71] L. Bilezikjian,et al. The cellular actions of vasopressin on corticotrophs of the anterior pituitary: resistance to glucocorticoid action. , 1987, Molecular endocrinology.
[72] P. Sawchenko,et al. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. , 1987, Endocrinology.
[73] A. Niendorf,et al. Cytochemical studies of corticotropin-releasing factor (CRF) receptors in anterior lobe corticotropes: binding, glucocorticoid regulation, and endocytosis of [biotinyl-Ser1]CRF. , 1986, Endocrinology.
[74] K. Catt,et al. Involvement of protein kinase C in the regulation of adrenocorticotropin release from rat anterior pituitary cells. , 1986, Endocrinology.
[75] I. Vermes,et al. Stress-induced secretion of adrenocorticotropin in rats is inhibited by administration of antisera to ovine corticotropin-releasing factor and vasopressin. , 1985, Endocrinology.
[76] A. Fischman,et al. In vivo potentiation of corticotropin releasing factor activity by vasopressin analogues. , 1984, Life sciences.
[77] W. Vale,et al. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat. , 1984, Endocrinology.
[78] W. Vale,et al. Corticotropin-releasing factor regulates proopiomelanocortin messenger ribonucleic acid levels in vivo. , 1984, Neuroendocrinology.
[79] B. Allolio,et al. Development of a non-extracted 'two-site' immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies. , 1984, The Biochemical journal.
[80] W. Vale,et al. Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. , 1983, Endocrinology.
[81] L. Bilezikjian,et al. Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3',5'-monophosphate in cultured anterior pituitary cells. , 1983, Endocrinology.
[82] G. Gillies,et al. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin , 1982, Nature.
[83] C. Saudek,et al. Two Phases of Adipose Tissue Metabolism in Pregnancy: Maternal Adaptations for Fetal Growth1 , 1973 .
[84] C. Saudek,et al. 2 phases of adipose tissue metabolism in pregnancy: maternal adaptations for fetal growth. , 1973, Endocrinology.